Natixis Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.5M | Sell |
|
|||||
|
2025
Q2 | $3.09M | Buy |
|
|||||
|
2025
Q1 | $4.54M | Buy |
|
|||||
|
2024
Q4 | $1.62M | Buy |
|
|||||
|
2024
Q3 | $1.3M | Buy |
|
|||||
|
2024
Q2 | $671K | Buy |
|
|||||
|
2024
Q1 | $449K | Sell |
|
|||||
|
2023
Q4 | $711K | Sell |
|
|||||
|
2023
Q3 | $648K | Buy |
|
|||||
|
2023
Q2 | $420K | Sell |
|
|||||
|
2023
Q1 | $444K | Buy |
|
|||||
|
2022
Q4 | $300K | Sell |
|
|||||
|
2022
Q3 | $485K | Buy |
|
|||||
|
2022
Q2 | $392K | Sell |
|
|||||
|
2022
Q1 | $418K | Buy |
|
|||||
|
2021
Q4 | $235K | Buy |
|